AXIN1 Protein: Biological Background

AXIN1 (Axis Inhibition Protein 1) is a multidomain scaffold protein that plays a pivotal role in the canonical Wnt/β-catenin signaling pathway. It functions as a central organizer of the β-catenin destruction complex, which also includes APC (adenomatous polyposis coli), glycogen synthase kinase 3β (GSK-3β), and casein kinase 1 (CK1). In the absence of Wnt ligand stimulation, this complex facilitates the phosphorylation, ubiquitination, and proteasomal degradation of β-catenin, thereby suppressing Wnt target gene expression.

When Wnt ligands bind to Frizzled receptors and LRP5/6 co-receptors, the destruction complex is inactivated, allowing β-catenin to accumulate in the cytoplasm, translocate to the nucleus, and activate TCF/LEF transcription factors. AXIN1 acts as a rate-limiting component of the destruction complex, making it a key regulator of Wnt pathway activity.

Loss-of-function mutations in the AXIN1 gene have been identified in various human cancers, including hepatocellular carcinoma, colorectal cancer, medulloblastoma, and adrenocortical carcinoma, underscoring its role as a tumor suppressor. AXIN1 also participates in other signaling cascades, including JNK and p53 pathways, through protein–protein interactions mediated by its DIX, RGS, and DAX domains.

AXIN1 Mouse mAb: Antibody Specifications

The AXIN1 Mouse mAb (catalog number Ab351162, cross-reference absea#KC-32794) is a monoclonal antibody generated in a mouse host, providing high specificity and lot-to-lot consistency for detection of AXIN1 protein. Key specifications are summarized below:

• Host Species: Mouse
• Antibody Class: Monoclonal
• Target Antigen: AXIN1 (Axis Inhibition Protein 1)
• Formulation: Supplied in phosphate-buffered saline (PBS) only. No preservatives, carrier proteins, or glycerol are listed; researchers should verify the full formulation sheet upon receipt.
• Storage: Store according to the conditions specified on the product datasheet. Monoclonal antibodies in PBS are generally stable at –20 °C for long-term storage; avoid repeated freeze–thaw cycles.

Because the product description references PBS-only formulation, users should consider adding a carrier protein (e.g., 0.1% BSA) and a preservative (e.g., 0.02% sodium azide) if aliquoting for long-term use, following standard laboratory practice. Always consult the product datasheet for validated conditions.

Recommended Applications and Protocol Guidelines

Monoclonal antibodies against AXIN1 are broadly employed in cell and molecular biology research. While the specific validated applications for Ab351162 should be confirmed on the official product datasheet, the following applications are typically relevant for anti-AXIN1 monoclonal antibodies:

• Western Blot (WB): AXIN1 runs at an apparent molecular weight of approximately 95–100 kDa on SDS-PAGE. Use standard denaturing conditions. Recommended starting dilutions are typically in the range of 1:500–1:2000; confirm with the datasheet. Positive control lysates include HEK293T, HeLa, or HCT116 cells.
• Immunoprecipitation (IP): AXIN1 Mouse mAb may be used to pull down AXIN1 and its interacting partners (e.g., GSK-3β, APC, β-catenin) from cell lysates prepared under native conditions.
• Immunofluorescence (IF) / Immunocytochemistry (ICC): AXIN1 localizes to punctate cytoplasmic structures (Axin puncta/signalosome). Paraformaldehyde fixation followed by detergent permeabilization is standard.
• Immunohistochemistry (IHC): Suitable for formalin-fixed, paraffin-embedded (FFPE) tissue sections with appropriate antigen retrieval (e.g., heat-induced epitope retrieval in citrate buffer, pH 6.0).

Note: Application validation data specific to Ab351162 should be obtained from the official Aladdin Scientific product datasheet. The applications listed above represent general guidance for this antibody class.

Sample Preparation and Troubleshooting Tips

Sample Preparation: For Western blot applications, lyse cells in RIPA buffer supplemented with protease and phosphatase inhibitor cocktails. AXIN1 is present at relatively low endogenous levels in many cell lines; enrichment by immunoprecipitation prior to Western blot may improve detection sensitivity. For tissue samples, snap-freeze in liquid nitrogen immediately after dissection to preserve protein integrity.

Blocking: Use 5% non-fat dry milk or 5% BSA in TBST depending on the detection method. BSA is preferred when detecting phosphorylated forms of interacting proteins in co-IP experiments.

Troubleshooting Common Issues:

• No signal / weak signal: Increase antibody concentration or prolong incubation. Verify that the cell or tissue type expresses AXIN1. Consider using a positive control (e.g., HCT116 lysate).
• High background: Extend washing steps, optimize blocking conditions, or reduce primary antibody concentration.
• Non-specific bands: Confirm band at the expected size (~95–100 kDa). Non-specific bands may arise from insufficient blocking or cross-reactivity; consult the datasheet for known cross-reactivities.
• Loss of signal after storage: Aliquot the antibody upon receipt to avoid repeated freeze–thaw cycles; store at –20 °C.

AXIN1 in Disease Research and Pathway Context

Given its tumor suppressor function, AXIN1 is a high-interest target across multiple research areas:

• Hepatocellular Carcinoma (HCC): Somatic mutations in AXIN1 are among the most frequent genetic alterations in HCC, leading to aberrant Wnt/β-catenin activation. AXIN1 Mouse mAb can be used to assess AXIN1 expression levels and protein stability in HCC cell lines and patient-derived tumor specimens.
• Colorectal Cancer: Although APC mutation is the predominant driver of Wnt pathway activation in colorectal cancer, AXIN1 mutations represent an alternative mechanism. Antibody-based detection can help stratify patient samples.
• Developmental Biology: AXIN1 is essential for embryonic axis formation; studies in model organisms have established its role in dorsoventral patterning. Researchers studying embryonic stem cell differentiation may use this antibody to monitor AXIN1 status during Wnt pathway modulation experiments.
• Drug Discovery: Small molecules that stabilize or mimic AXIN function (tankyrase inhibitors, for example) are under investigation as Wnt pathway inhibitors. AXIN1 Mouse mAb serves as a valuable tool antibody to monitor target engagement and AXIN1 protein levels in these studies.

When designing experiments, researchers should include appropriate positive and negative controls, and be aware of the tumor suppressor context of AXIN1 when interpreting results from cancer cell lines that may carry AXIN1 loss-of-function mutations.